Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative Colitis

Overview of attention for article published in Clinical Gastroenterology and Hepatology, September 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 4 news outlets
twitter: 54 X users

facebook: 1 Facebook page
f1000: 1 research highlight platform

Citations

dimensions_citation: 146 Dimensions

Readers on

mendeley: 164 Mendeley

Summary News X Facebook Research highlights Dimensions citations

So far, Altmetric has seen 1 public wall post.

Aegastro, 19 Jan 2019

Colitis ulcerosa moderada - grave que no responde a corticoides, IS - antiTNFalfa. Tofacitinib (inhibidor de JAK) 10 mg cada 12…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.